PELLC is a privately held preclinical services consulting firm consisting of expert toxicologic pathologists who service the histopathology, toxicology and preclinical needs of biotechnology and pharmaceutical companies in North America, Europe & Asia.

News:

PELLC offering select clients webinars on how "Virtual Preclinical Services" can augment their product development efforts
Dr. Frank Voelker will be giving a workshop on "Image Analysis in Tox Pathology" at STP Annual conference 6/25
William O. Iverson - DVM, Diplomate, ACVP, ABT, joins PELLC as an Expert and as a member of the Executive Team focusing on Business Development in North America. 5/08
PELLC forms Board of Directors, initially consisting of Maurice Cary, CEO, Jack Robinson EVP & investor and John Reddington, outside director. Two additional outside directors will be added. 5/08

Overview:

Pathology Experts LLC Provides senior level expertise, in the area of histopathology, to our clients in the pharmaceutical and biotechnology industries.

These customers require the caliber of expertise offered by PELLC to support critical, time sensitive decision making concerning compounds in the preclinical and Phase I stages of development and beyond. Our focus is on delivering high quality and high value service to our clients to meet their corporate milestones. PELLC provides peer review and troubleshooting expertise to clients, as well as GLP certified histopathology, regulatory document preparation, study placement and monitoring, and due diligence in support of M&A and licensing activities where detailed assessments of compounds in development represent a significant portion of the value of the transaction.

PELLC Experts are available for assignments in North America and Europe with offices in Basel Switzerland and Rye NY.

When it is your most important compound, when it is time critical, when it has to be right the first time, contact Pathology Experts LLC!